1-156242823-A-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001199661.1(PMF1-BGLAP):āc.604A>Gā(p.Met202Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000438 in 1,596,908 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001199661.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
BGLAP | NM_199173.6 | c.165A>G | p.Gln55Gln | synonymous_variant | 3/4 | ENST00000368272.5 | NP_954642.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
BGLAP | ENST00000368272.5 | c.165A>G | p.Gln55Gln | synonymous_variant | 3/4 | 1 | NM_199173.6 | ENSP00000357255.4 | ||
PMF1-BGLAP | ENST00000490491.5 | c.*29A>G | 3_prime_UTR_variant | 6/7 | 2 | ENSP00000475561.1 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152194Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000841 AC: 2AN: 237676Hom.: 0 AF XY: 0.00000780 AC XY: 1AN XY: 128262
GnomAD4 exome AF: 0.00000415 AC: 6AN: 1444596Hom.: 0 Cov.: 32 AF XY: 0.00000418 AC XY: 3AN XY: 716918
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152312Hom.: 0 Cov.: 32 AF XY: 0.0000134 AC XY: 1AN XY: 74470
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 20, 2021 | The c.604A>G (p.M202V) alteration is located in exon 6 (coding exon 6) of the PMF1-BGLAP gene. This alteration results from a A to G substitution at nucleotide position 604, causing the methionine (M) at amino acid position 202 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at